Add like
Add dislike
Add to saved papers

Glycolytic inhibitor 2-deoxy-D-glucose at chronic low dose mimics calorie restriction in rats through mitohormetic induction of ROS.

Rejuvenation Research 2018 November 19
Caloric restriction mimetics (CRMs) provide an exciting anti-aging intervention strategy. 2-deoxy-D-glucose (2-DG), a glycolytic inhibitor is known to works as a CRM at high doses, however chronic high dose has been linked to increased mortality in rats. We have investigated chronic low dose dietary administration of 2-DG on age-related stress protection in young and old age male wistar rats by evaluating age-dependent biomarkers in plasma and erythrocytes. Significant increase was observed in ROS generation in 2-DG treated rats (both young and old), concomitant with increase in erythrocyte plasma membrane redox system (PMRS), catalase (CAT) and superoxide dismutase (SOD). 2-DG treatment also decreased plasma sialic acid and advanced glycation end products (AGEs). We propose that 2-DG induces a mitohormetic response resulting in augmentation of defence mechanism(s) manifested by higher activity of PMRS, CAT and SOD. Our findings provide evidence that at chronic low dose 2-DG could be a potential CRM.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app